The global Irritable Bowel Syndrome (IBS) Treatment Market was valued at USD 1.47 billion in 2022 and is projected to reach USD 2.81 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4% over the forecast period from 2023 to 2030. The increasing prevalence of gastrointestinal disorders, rising awareness about IBS, and the growing demand for targeted therapies are expected to drive significant growth in the IBS treatment market.Market OverviewIrritable bowel syndrome (IBS) is a com...
more